![Tracey O’Brien: The Cancer Institute NSW welcomes the launch of the Australian Government’s first national Cancer Plan](https://oncodaily.com/pub/uploads/2023/09/1687830824190-e1699122953823.jpeg)
Tracey O’Brien: The Cancer Institute NSW welcomes the launch of the Australian Government’s first national Cancer Plan
Tracey O’Brien recently posted on LinkedIn:
“The Cancer Institute NSW welcomes the launch of the Australian Government’s first national Cancer Plan, a 10-year framework to address the burden of cancer and reduce its devastating impact on our community.
The national plan aligns with the objectives of the NSW Cancer Plan 2022-2027, and the newly released Aboriginal and Torres Strait Islander Cancer Plan, with equity and person-centredness at its heart.
Despite great strides in cancer care and research, cancer’s burden is increasing, with more than 164,000 Australians projected to be diagnosed with the disease this year. It’s hoped that together with the efforts taking place in each state and territory, the National Cancer Plan will help bring us that one step closer to reducing cancer’s impact on all Australians.
Read the plan here. ”
Source: Tracey O’Brien/LinkedIn
Dr. Tracey O’Brien is the NSW Chief Cancer Officer and CEO of the Cancer Institute NSW, Australia. Before her current role, Tracey was the Director of the Kids Cancer Centre, Sydney Children’s Hospital, and Director of the Transplant & Cellular Therapy Program. Tracey has held numerous high-profile national and international leadership positions, including Advisory Chair, Cancer Australia; V/Chair (Africa, Asia and Australasia) International Centre for Bone Marrow Transplant Research and V/President of the Australian and New Zealand Children’s Oncology Group. In recognition of her exceptional contributions, Tracey was profiled in 2023 as one of the world’s foremost women in paediatric cancer by the International Society of Paediatric Oncology. In 2019 Tracey was named in the Australian Financial Review’s prestigious Top 10 Women of Influence, winning the Innovation category. In addition to her medical expertise, Tracey has a Master of Law (Health) and executive MBA and serves as a conjoint Professor in Clinical Medicine (UNSW) and Honorary Professor in Science and Engineering (Macquarie University). Dr. O’Brien remains committed to mentoring the next generation of clinician leaders and maintains an active clinical practice in cancer survivorship at Sydney Children’s Hospital.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023